Liquid cancer test offers hope for alternative to painful biopsies
Chicago
A BLOOD test to detect cancer mutations produced results that generally agree with those of an invasive tumour biopsy, researchers reported, heralding a time when diagnosing cancer and monitoring its progression may become less painful and risky.
The blood tests, known as liquid biopsies, represent one of the hottest trends in oncology. They take advantage of the fact that DNA fragments from tumours can be found in tiny amounts in the blood of patients with cancer.
Researchers hope that such tests can become alternatives to conventional tumour biopsies, in which a piece of the tumour is extracted by needle or by surgery - procedures that can have complications.
The results of the study, the largest to date of a liquid biopsy test, give some reassurance th…
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Consumer & Healthcare
Hermes Q1 sales jump 17% on strong China demand
Cordlife’s independent auditor to retire after issuing disclaimer of opinion on FY2023 financials
Cutting the cord?: Events leading up to Cordlife’s MOH suspension and arrests of its directors, ex-group CEO
Cordlife customers push for legal action
France's Casino supermarket chain to axe up to 3,200 jobs
Prada outshines rivals with 16% revenue lift boosted by Miu Miu